About Stem Cell Banking
The global stem cell banking market is a closely related market to the global regenerative medicine market. Regenerative medicine is a key branch of modern medicine, which has emerged as a combination of tissue engineering and molecular biology. Regenerative medicine aims to re-engineer human cells, tissues, or organs, which can replace or restore the normal functioning of impaired cells, tissues; or organs.
Technavio’s analysts forecast the global stem cell banking market to grow at a CAGR of 12.76% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global stem cell banking market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Stem Cell Banking Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• AMAG Pharmaceuticals
• Cordlife
• Cryo-Cell International
• Esperite
Other prominent vendors
• Cellular Dynamics International
• China Cord Blood Corporation
• Cordvida
• Cryo Stemcell
• Cryoviva India
• Cytori Therapeutics
• Lifecell
• PerkinElmer
• Reelabs
• Smart Cells International
• Stemade Biotech
• StemCyte
Market driver
• Growing prevalence of cancer
• For a full, detailed list, view our report
Market trend
• Growing acceptance of stem cell therapies
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: MARKET SEGMENTATION BY CELL TYPE
• Overview
• Comparison by cell type
• Adult stem cells
• Umbilical cord blood stem cells
• Embryonic stem cells
• Market opportunity by cell type
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Stem cell banking market in Americas
• Stem cell banking market in EMEA
• Stem cell banking market in APAC
• Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 12: MARKET TRENDS
• Increasing implementation of inorganic growth strategies
• Rising demand for personalized medicines
• Growing acceptance of stem cell therapies
PART 13: VENDOR LANDSCAPE
• Competitive scenario
PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• AMAG Pharmaceuticals
• Cordlife
• Cryo-Cell International
• Esperite
• Other prominent vendors
PART 15: APPENDIX
• List of abbreviations
List of Exhibits
Exhibit 01: Global stem cell banking market: Related market
Exhibit 02: Global stem cell banking market: Market characteristics
Exhibit 03: Global stem cell banking market: Market segments
Exhibit 04: Market definition: Inclusions and exclusions checklist
Exhibit 05: Global stem cell banking market: Market size 2017
Exhibit 06: Validation techniques employed for market sizing 2017
Exhibit 07: Global stem cell banking market: Market size and forecast 2017-2022 ($ billions)
Exhibit 08: Global stem cell banking market: Year-over-year growth 2017-2022 (%)
Exhibit 09: Five forces analysis 2017
Exhibit 10: Five forces analysis 2022
Exhibit 11: Bargaining power of suppliers
Exhibit 12: Threat of new entrants
Exhibit 13: Threat of substitutes
Exhibit 14: Threat of rivalry
Exhibit 15: Market condition: Five forces 2017
Exhibit 16: Market condition: Five forces 2022
Exhibit 17: Global stem cell banking market: Segmentation by cell type 2017-2022 (% share)
Exhibit 18: Global stem cell banking market: Comparison by cell type
Exhibit 19: Global adult stem cell banking market 2017-2022 ($ billions)
Exhibit 20: Global adult stem cell banking market: Year-over-year growth 2018-2022 (%)
Exhibit 21: Global umbilical cord blood stem cell banking market 2017-2022 ($ billions)
Exhibit 22: Global umbilical cord blood stem cell banking market: Year-over-year growth 2018-2022 (%)
Exhibit 23: Global embryonic stem cell banking market 2017-2022 ($ billions)
Exhibit 24: Global embryonic stem cell banking market: Year-over-year growth 2018-2022 (%)
Exhibit 25: Global stem cell banking market: Market opportunity by cell type
Exhibit 26: Global stem cell banking market: Customer landscape
Exhibit 27: Global stem cell banking market: Segmentation by geography 2017-2022 (% share)
Exhibit 28: Regional comparison
Exhibit 29: Stem cell banking market in Americas 2017-2022 ($ billions)
Exhibit 30: Stem cell banking market in Americas: Year-over-year growth 2018-2022 (%)
Exhibit 31: Top three countries in Americas
Exhibit 32: Stem cell banking market in EMEA 2017-2022 ($ billions)
Exhibit 33: Stem cell banking market in EMEA: Year-over-year growth 2018-2022 (%)
Exhibit 34: Top three countries in EMEA
Exhibit 35: Stem cell banking market in APAC 2017-2022 ($ billions)
Exhibit 36: Stem cell banking market in APAC: Year-over-year growth 2018-2022 (%)
Exhibit 37: Top three countries in APAC
Exhibit 38: Cancer severity across EU in 2013 and cancer incidence in US in 2014
Exhibit 39: Year-over-Year growth and growth rate of stem cell research spending in US 2013-2016 ($ billions)
Exhibit 40: CIRM funding in stem cell research 2014 ($ billions)
Exhibit 41: CIRM active programs 2014
Exhibit 42: EC funding for regenerative medicine
Exhibit 43: Strategic success factors of vendors in market
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: AMAG Pharmaceuticals: Overview
Exhibit 47: AMAG Pharmaceuticals: Business segments
Exhibit 48: AMAG Pharmaceuticals: Organizational developments
Exhibit 49: AMAG Pharmaceuticals: Geographic focus
Exhibit 50: AMAG Pharmaceuticals: Segment focus
Exhibit 51: AMAG Pharmaceuticals: Key offerings
Exhibit 52: Cordlife: Overview
Exhibit 53: Cordlife: Business segments
Exhibit 54: Cordlife: Organizational developments
Exhibit 55: Cordlife: Geographic focus
Exhibit 56: Cordlife: Segment focus
Exhibit 57: Cordlife: Key offerings
Exhibit 58: Cryo-Cell International: Overview
Exhibit 59: Cryo-Cell International: Business segments
Exhibit 60: Cryo-Cell International: Organizational developments
Exhibit 61: Cryo-Cell International: Geographic focus
Exhibit 62: Cryo-Cell International: Segment focus
Exhibit 63: Cryo-Cell International: Key offerings
Exhibit 64: Esperite: Overview
Exhibit 65: Esperite: Business segments
Exhibit 66: Esperite: Organizational developments
Exhibit 67: Esperite: Geographic focus
Exhibit 68: Esperite: Segment focus
Exhibit 69: Esperite: Key offerings
